Abstract:BACKGROUND:At present, studies on MircoRNA-22-3p (miR-22-3p) in lung adenocarcinoma use a single method, lack multi-center validation and multi-method validation, and there is no big data concept to predict and validate target genes.OBJECTIVE:To investigate the expression, potential targets and clinicopathological significance of miR-22-3p in lung adenocarcinoma (LUAD) tissues.METHODS:LUAD formalin-fixed paraffin-embedded (FFPE) tumors and adjacent normal lung tissues were collected for real-time quantitative polymerase chain reaction (RT-qPCR). Collect miR-22-3p in LUAD and non-cancer lung tissue from high-throughput datasets, standardized mean difference (SMD) and area under the curve (AUC) of the comprehensive receiver operating curve (summary receiver operating characteristic cure, sROC curve) were calculated. Cell function experiments on A549 cells transfected with LV-hsa-miR-22-3p. Target genes were predicted by the miRwalk2.0 website and the resulting target genes were subjected to Gene Ontology (GO) pathway enrichment analysis and constructed to protein-protein interaction network. Finally, the protein expression level of the key gene TP53 was validated by searching The Human Protein Atlas (THPA) database to incorporate TP53 immunohistochemical results in LUAD.RESULTS:RT-qPCR result from 41 pairs of LUAD and adjacent lung tissues showed that miR-22-3p was downregulated in LUAD (AUC = 0.6597, p= 0.0128). Globally, a total of 838 LUADs and 494 non-cancerous lung tissues were included, and were finally combined into 14 platforms. Compared with noncancerous tissue, miR-22-3p expression level was significantly reduced in LUAD tissue (SMD =-0.32, AUC = 0.72l); cell function experiments showed that miR-22-3p has inhibitory effects on cell proliferation, migration and invasion, and has promotion effect on apoptosis. Moreover, target genes prediction, GO pathway enrichment analysis and PPI network exhibited TP53 as a key gene of target gene of miR-22-3p; at last, a total of 114 high-throughput datasets were included, including 3897 LUADs and 2993 non-cancerous lung tissues, and were finally combined into 37 platforms. Compared with noncancerous tissue, TP53 expression level was significantly increased in LUAD (SMD = 0.39, p< 0.01) and it was verified by the protein expression data from THPA.CONCLUSION:Overexpression of miR-22-3p may inhibit LUAD cell proliferation, migration and invasion through TP53, and promote cell apoptosis.

Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases

Identification of Stage-associated MicroRNAs in Lung Adenocarcinoma Based on Microarray Data

Clinical Significance of High Expression of Mir-452-5p in Lung Squamous Cell Carcinoma.

Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma

Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis

Clinical Value of Microrna-198-5p Downregulation in Lung Adenocarcinoma and Its Potential Pathways.

Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data

MiR-452-5 p may serve as an oncogene in colorectal cancer through targeting CDKN 1 B : a study based on bioinformatics analysis and dual-luciferase reporter assay

Aberrant Expression of SCARA5 in Lung Adenocarcinoma and its Clinical Significance

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Clinical Value of Mir-182-5p in Lung Squamous Cell Carcinoma: a Study Combining Data from TCGA, GEO, and RT-qPCR Validation

The Suppressive Role of Mir-542-5p in NSCLC: the Evidence from Clinical Data and in Vivo Validation Using a Chick Chorioallantoic Membrane Model

A Meta-Analysis And Bioinformatics Exploration Of The Diagnostic Value And Molecular Mechanism Of Mir-193a-5p In Lung Cancer

The Clinical Significance and Mechanism of Microrna-22-3p Targeting TP53 in Lung Adenocarcinoma.

Expression Levels And Co-Targets Of Mirna-126-3p And Mirna-126-5p In Lung Adenocarcinoma Tissues: N Exploration With Rt-Qpcr, Microarray And Bioinformatic Analyses

Mir-550A-5p Functions As a Tumor Promoter by Targeting LIMD1 in Lung Adenocarcinoma

Down-Regulation of Mir-452 is Associated with Poor Prognosis in the Non-Small-Cell Lung Cancer

[Expression of MiR-148b-3p in Lung Adenocarcinoma and Its Correlation with Prognosis].

Expression, Clinical Significance, Immune Infiltration, and Regulation Network of miR-3940-5p in Lung Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation

Clinical Value and Potential Mechanism of Mirna-33A-5p in Lung Squamous Cell Carcinoma

Potential Targets and Clinical Value of Mir-490-5p in Hepatocellular Carcinoma: a Study Based on TCGA, Qrt-Pcr and Bioinformatics Analyses.